In 2021, the ARAG Group once again significantly increased its gross premium revenues by 9.1 per cent from €1.85 billion to €2.02 billion.
Including income from service companies, the Group generated total revenues of €2.04 billion. The underwriting result improved by 5.5 per cent, reaching another record level of €118.2 million. The profit on ordinary activities amounted to €86.7 million.
“Consumers are responding to a crisis with an increased need for cover, which is strongly focused on the areas of work and health – and hence on legal and health insurance. Our customers rely on us for help and protection and reward our corresponding efforts. This is reflected very clearly in how our business has developed in 2021,” explained Dr. Renko Dirksen, Speaker of the Board of Management of ARAG SE, at the presentation of the ARAG Group’s financial statements.
Despite the pandemic, the ARAG Group continued to post strong growth in Germany in 2021. Here, premium revenues rose by 9.6 per cent, well above the market average. Growth in international business was also strong at 8.5 per cent. At the end of 2021, the ARAG Group had a total of 12.2 million policies in its portfolio. The Group’s combined ratio increased to 89.2 per cent, up from 87.6 per cent in 2020, while claims expenses rose to €1.03 billion from €935.6 million in the previous year. Due to the strong premium growth, the Group’s claims ratio moved from 50.9 per cent to 51.7 per cent. The cost ratio went up from 36.7 per cent to 37.5 per cent as a result of dynamic growth. Income from capital investments benefited in 2021 from a generally good market development with rising stock prices. It rose to €80.3 million, compared with €78.4 million in the previous year. Profit on ordinary activities showed a 4 percent increase on balance and climbed to €86.7 million (previous year: €83.2 million).
The record high in premium income is primarily attributable to the strong performance of the legal insurance segment – the largest unit in the Group. Here, premium growth amounted to 10.9 per cent in Germany and 7.8 per cent in international business. The health insurance segment delivered a particularly strong premium gain of 12.6 per cent, mainly driven by the successful new full-cost health insurance rates. The composite segment recovered from pandemic-related declines in 2021. Revenue here has gone up by 4.2 per cent.
Outlook for the current business year 2022
The enormous momentum of the ARAG Group continued into the first quarter of 2022 – with the best start to the year in the company’s history. Premium income in the first quarter continued to grow strongly by 10.4 per cent to € 638 million (previous year: € 576.4 million). In the German market, the Group delivered strong premium growth of 8.4 per cent. The national growth drivers were health insurance with 14 per cent growth and legal insurance with 6.6 per cent. ARAG also got off to an excellent start internationally, posting a 14 per cent increase in premium revenues.
“Despite this brilliant start, we are not expecting record figures for our business again in business year 2022. Above all, the effects of a strong inflation are unclear and will be crucial,” emphasized Dr. Renko Dirksen. However, thanks to its modern and at the same time robust positioning as well as highly successful business development, the ARAG Group can face the future with confidence:
“We are not closing our eyes to the noticeable changes in our world and economic order,” emphasized Dr. Renko Dirksen. “With our business model, we offer our customers effective protection for their standard of living in uncertain times. Our customers need us right now – and we will deliver,” says the Board Speaker. One of ARAG’s clear strengths is that it grows with the challenges it faces. ARAG delivered proof of that in the pandemic – and significantly expanded its business under extremely difficult conditions. “This attitude will also help us to find our way in a world of unresolved geopolitical conflicts and to continue working with calm assurance on our success story,” underlines Dr. Renko Dirksen.